Loxo Oncology (LOXO) Tops Q1 EPS by 15c

Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.35), $0.15 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Royal Unibrew reports higher interim first-half profit as margins improve